Clinical Trial Update: Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration [Phase 1]

View source ↗

Summary

Phase 1 trial update describing inter-SPORE collaboration evaluating novel PET/CT imaging agents and MR spectroscopy/MRI for prostate cancer and high-risk prost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED